Adtalem Global Education Inc. (NYSE:CVSA – Free Report) – Stock analysts at Zacks Research cut their Q1 2027 EPS estimates for Adtalem Global Education in a research note issued to investors on Thursday, August 20th. Zacks Research analyst Team now forecasts that the company will earn $1.97 per share for the quarter, down from their previous forecast of $2.00. The consensus estimate for Adtalem Global Education’s current full-year earnings is $8.99 per share. Zacks Research also issued estimates for Adtalem Global Education’s Q2 2027 earnings at $2.38 EPS, Q4 2027 earnings at $2.28 EPS, Q1 2028 earnings at $2.30 EPS, Q2 2028 earnings at $2.56 EPS, Q3 2028 earnings at $2.50 EPS, Q4 2028 earnings at $2.59 EPS, FY2028 earnings at $9.94 EPS and FY2029 earnings at $11.53 EPS.
Several other research analysts have also commented on CVSA. Barrington Research reiterated an “outperform” rating and issued a $170.00 target price on shares of Adtalem Global Education in a research report on Monday, June 8th. Truist Financial upped their price target on Adtalem Global Education from $130.00 to $140.00 and gave the company a “buy” rating in a research report on Monday, May 11th. Weiss Ratings restated a “hold (c+)” rating on shares of Adtalem Global Education in a research note on Wednesday. Finally, Wall Street Zen upgraded shares of Adtalem Global Education from a “hold” rating to a “buy” rating in a research note on Saturday, August 8th. Two analysts have rated the stock with a Buy rating and two have given a Hold rating to the company’s stock. According to MarketBeat.com, the company has a consensus rating of “Moderate Buy” and a consensus price target of $155.00.
Adtalem Global Education Stock Down 2.7%
Shares of NYSE CVSA opened at $128.38 on Friday. The company has a debt-to-equity ratio of 0.45, a current ratio of 1.09 and a quick ratio of 1.09. The company’s 50 day moving average price is $125.46. Adtalem Global Education has a 52-week low of $86.97 and a 52-week high of $156.26. The firm has a market capitalization of $4.37 billion, a PE ratio of 18.24, a P/E/G ratio of 0.98 and a beta of 0.62.
Adtalem Global Education (NYSE:CVSA – Get Free Report) last released its earnings results on Thursday, August 6th. The company reported $2.09 earnings per share for the quarter, topping the consensus estimate of $1.90 by $0.19. Adtalem Global Education had a net margin of 12.87% and a return on equity of 20.88%. The company had revenue of $501.38 million during the quarter. Adtalem Global Education has set its FY 2027 guidance at 8.900-9.150 EPS.
Institutional Inflows and Outflows
A hedge fund recently bought a new stake in Adtalem Global Education stock. Kendall Capital Management acquired a new stake in Adtalem Global Education Inc. (NYSE:CVSA – Free Report) in the 2nd quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The firm acquired 11,622 shares of the company’s stock, valued at approximately $1,449,000. 98.84% of the stock is currently owned by institutional investors and hedge funds.
Insider Buying and Selling
In related news, CEO Stephen W. Beard sold 3,545 shares of the business’s stock in a transaction that occurred on Tuesday, August 11th. The stock was sold at an average price of $130.34, for a total transaction of $462,055.30. Following the completion of the transaction, the chief executive officer owned 415,197 shares in the company, valued at $54,116,776.98. The trade was a 0.85% decrease in their position. The transaction was disclosed in a document filed with the SEC, which is available through this hyperlink. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Also, SVP Douglas G. Beck sold 4,526 shares of the firm’s stock in a transaction on Friday, August 7th. The shares were sold at an average price of $135.81, for a total value of $614,676.06. Following the completion of the sale, the senior vice president owned 28,544 shares in the company, valued at $3,876,560.64. The trade was a 13.69% decrease in their ownership of the stock. The SEC filing for this sale provides additional information. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. In the last 90 days, insiders have sold 25,951 shares of company stock valued at $3,470,783. Insiders own 2.50% of the company’s stock.
Adtalem Global Education Company Profile
Adtalem Global Education (NYSE: CVSA) is a provider of higher education and workforce solutions focused primarily on programs that prepare students for professional careers in healthcare, medicine, veterinary medicine and related fields. The company operates campus-based and online degree programs, continuing professional education, clinical training and exam-preparation offerings designed to support students seeking licensure and employment in regulated professions.
Adtalem’s portfolio includes institution brands that deliver undergraduate, graduate and professional training across nursing, medicine, veterinary medicine and allied health disciplines.
Featured Articles
- Five stocks we like better than Adtalem Global Education
- Coherent Stock Is Cooling Off Just as Its AI Thermal Opportunity Heats Up
- Moderna’s 177% Surge Has Investors Asking What Comes Next
- 3 Energy Stocks Raising Dividends as the Sector Surges
- 5 Reasons the S&P 500 Could Keep Rallying Through Year-End
Receive News & Ratings for Adtalem Global Education Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Adtalem Global Education and related companies with MarketBeat.com's FREE daily email newsletter.
